Lymphoma
Basic details
Preferred term: Lymphoma
Alt. terms: Cancer of lymphatic system
HPO term: Lymphoma
HPO code: HP:0002665
GenIA ID: 53
Last updated on: 2021-12-10 17:55:48
Cross ref. with other ontologies
NCIT: C3208
MESH: D008223
EFO: -
OAE: -
SNOMEDCT: -
ICD10: -
Description
A malignant (clonal) proliferation (cancer) of B- lymphocytes or T- lymphocytes that involves the lymph nodes, bone marrow and/or extranodal sites, and that presents as solid tumor. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.
Hierarchical classification
PARENT terms
TERM
Lymphoma
Reported patients added to GenIA DB
SubjectID | Sex | Fam.ID | Age* | Population | MatchedTerm | Diagnosis | Reference & Pub.codes |
---|---|---|---|---|---|---|---|
101015 | M | 210203 | -,33 | German | Hodgkin lymphoma,Lymphoma | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:30250467 [Fam.MM:II.1]; PMID:29729943 [Fam.MM:II.1(87)]; PMID:34975878 [Fam.F002:P002]; PMID:31857261 [Patient 3] |
101023 | M | 210731 | 50 | German | Non-Hodgkin lymphoma | PMID:34975878 [Fam.F008:P008] | |
101037 | M | 210182![]() |
51,- | Caucasian | Hodgkin lymphoma,Lymphoma | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:25329329 [Fam.B:II.4(B.II.3)]; PMID:30250467 [B.II.3]; PMID:29729943 [Fam.B:II.4(B.II.3 (15))]; PMID:27418640 [P13(5)] |
101051 | F | 210205![]() |
30 | Caucasian | Hodgkin lymphoma | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:25329329 [Fam.A:III.5(A.III.1)]; PMID:30250467 [A.III.1]; PMID:29729943 [Fam.A:III.5(A.III.1 (8))]; PMID:34975878 [Fam.F018:III.1(P021)]; PMID:27418640 [P10(5)] |
101076 | F | 210226 | 53 | German | Non-Hodgkin lymphoma | PMID:34975878 [Fam.F041:P041] | |
101088 | M | 211560 | 38 | German | Non-Hodgkin lymphoma | PMID:34975878 [Fam.F054:P054] | |
101090 | M | 211257 | - | Hodgkin lymphoma | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:34975878 [Fam.F056:P056]; PMID:37740092 [P13] | |
101104 | F | 211429 | 19 | Hodgkin lymphoma | Activated p110-delta syndrome 1 | PMID:34975878 [Fam.F397:P397] | |
101121 | M | 210784 | 47 | German | Lymphoma | PMID:34975878 [Fam.F072:P072] | |
101133 | M | 210896 | 38 | Non-Hodgkin lymphoma | Immunodeficiency, common variable, 13 | PMID:34975878 [Fam.F082:P082] | |
101155 | M | 210235 | -,28,- | German | Hematological neoplasm,Hodgkin lymphoma,Lymphoma | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:30250467 [JJ.II.I]; PMID:29729943 [Fam.JJ:II.1(83)]; PMID:34975878 [Fam.F098:P098] |
101160 | F | 211433 | -,- | Hematological neoplasm,Non-Hodgkin lymphoma | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:34975878 [Fam.F101:P101] | |
101387 | M | 211537 | - | German | Hematological neoplasm | PMID:34975878 [Fam.F136:P136] | |
101441 | M | 212174 | 19 | North American | Non-Hodgkin lymphoma | Immunodeficiency, common variable, 8 | PMID:26206937 [P6] |
101462 | M | 210006 | - | Hematological neoplasm | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:34975878 [Fam.F154:P154] | |
101544 | F | 211170 | - | Hematological neoplasm | PMID:34975878 [Fam.F180:P180] | ||
101549 | F | 212463 | - | British | Lymphoma | Activated p110-delta syndrome 1 | PMID:24136356 [Fam.E:I.1(P13)] |
101808 | F | 211441 | -,- | Hematological neoplasm,Non-Hodgkin lymphoma | Immunodeficiency, common variable, 2 | PMID:34975878 [Fam.F265:P265] | |
101951 | M | 212062 | - | Hematological neoplasm | PMID:34975878 [Fam.F375:P375] | ||
102175 | M | 210725![]() |
-,21 | Caucasian | Hodgkin lymphoma,Lymphoma | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:30250467 [Fam.H:II.1]; PMID:29729943 [Fam.H:II.1(29)] |
102222 | M | 214917 | 44 | German | Non-Hodgkin lymphoma | NFKB1 insufficiency | PMID:32278790 [BY.I.1]; PMID:35486341 [P074]; PMID:150198 [Fam.DJ:467]; PMID:36105815 [W295C] |
102225 | M | 214920 | - | Romanian | Lymphoma | Immunodeficiency 40 | PMID:35486341 [P063] |
102803 | F | 214991![]() |
16,16 | North American | Hodgkin lymphoma,Lymphoma | Immunodeficiency 8 | PMID:25073507 [P1(II.2)] |
103061 | M | 215095![]() |
6 | Finnish | Hodgkin lymphoma | Seizures, cortical blindness, microcephaly syndrome | PMID:33662367 [Fam.F1:II.9(P2)] |
103788 | M | 215242![]() |
- | South Korean | Lymphoma | Hyper-IgE recurrent infection syndrome 1 | PMID:19348930 [Patient(II.1)] |
103929 | M | 215279 | 34 | French | Non-Hodgkin lymphoma | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K10:P12] |
103938 | M | 215285 | 17 | French | Non-Hodgkin lymphoma | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K16:P20] |
103946 | F | 215290 | 8 | French | Non-Hodgkin lymphoma | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K20:P25] |
103947 | F | 215291 | 21 | French | Non-Hodgkin lymphoma | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K21:P26] |
104011 | M | 215327![]() |
- | Hodgkin lymphoma | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:25359994 [Fam.2:I.2(P13)] | |
104357 | M | 215496 | - | French | Non-Hodgkin lymphoma | Hyper-IgE recurrent infection syndrome 1 | PMID:22084479 [P2] |
104361 | M | 215500 | - | French | Non-Hodgkin lymphoma | Hyper-IgE recurrent infection syndrome 1 | PMID:22084479 [P6] |
104365 | F | 215504 | - | French | Non-Hodgkin lymphoma | Hyper-IgE recurrent infection syndrome 1 | PMID:22084479 [P10] |
104791 | M | 215575![]() |
10 | Hodgkin lymphoma | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:25213377 [Fam.C:II.1(C.II.1)]; PMID:27418640 [P4(4)] | |
104845 | F | 215579![]() |
35 | European | Non-Hodgkin lymphoma | NFKB1 insufficiency | PMID:32278790 [Fam.NZ:II.2(II.2)]; PMID:26279205 [Fam.NZ:II.2(II2)]; PMID:29403474 [Fam.NZ (5):II.2(II2)]; PMID:29806948 [Fam.NZ:II.2(II.2)]; PMID:30323807 [Fam.2:II.2(II.2)]; PMID:150198 [Fam.AC:II.2(109)] |
105173 | M | 215659 | - | Non-Hodgkin lymphoma | PMID:27102614 [Fam.A:I.1(father)] | ||
105177 | M | 215661 | -,16 | Caucasian | Hodgkin lymphoma,Lymphoma | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:30250467 [L.II.2]; PMID:29729943 [Fam.L:II.2(L.II.2 (36))]; PMID:27102614 [Fam.C:II.2(4)] |
105182 | F | 215662 | - | Gastric lymphoma | PMID:27102614 [Fam.D:I.2(mother)] | ||
105280 | M | 215685![]() |
68 | European | Non-Hodgkin lymphoma | NFKB1 insufficiency | PMID:32278790 [Fam.B:I.1(I.1)]; PMID:29477724 [Fam.B:I.1(I:1)]; PMID:150198 [Fam.AV:I.1(242)] |
105513 | F | 215787![]() |
- | Caucasian | Hodgkin lymphoma | Activated p110-delta syndrome 1 | PMID:24165795 [Fam.F:II.1(F.II.1)] |
105568 | M | 215809 | 11 | Hodgkin lymphoma | Activated p110-delta syndrome 1 | PMID:24698326 [Fam.A:II.1(P2)] | |
105591 | F | 215821 | 16 | Caucasian | Non-Hodgkin lymphoma | Activated p110-delta syndrome 1 | PMID:24610295 [Fam.2:II.1(F2P2)] |
105607 | F | 215821 | 21 | Caucasian | Hodgkin lymphoma | PMID:24610295 [Fam.2:II.3] | |
105609 | M | 215821 | - | Caucasian | MALT lymphoma | Activated p110-delta syndrome 1 | PMID:24610295 [Fam.2:III.1(F2P3)] |
105910 | F | 215905 | 45,- | Caucasian | Lymphoma,Non-Hodgkin lymphoma | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:30250467 [K.II.1]; PMID:29729943 [Fam.K:II.1(K.II.1 (33))] |
106042 | M | 215927 | -,22 | North American | Lymphoma,Non-Hodgkin lymphoma | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:30250467 [FF.II.1]; PMID:29729943 [Fam.FF:II.1(FF.II.1 (77))] |
106161 | M | 215960 | - | Turkish | Hodgkin lymphoma | Immunodeficiency, common variable, 8 | PMID:31432443 [P5] |
106164 | M | 215963 | - | Turkish | Non-Hodgkin lymphoma | Immunodeficiency, common variable, 8 | PMID:31432443 [P8] |
106169 | F | 215968 | - | Turkish | Non-Hodgkin lymphoma | Immunodeficiency, common variable, 8 | PMID:31432443 [P13] |
106256 | F | 215977 | - | Caucasian | Lymphoma | PMID:30250467 [UU.III.3]; PMID:29729943 [Fam.UU:III.4(UU.III.3 (108))]; PMID:29305966 [Fam.IV.2:III.9(III.11)] | |
106321 | M | 215688![]() |
- | European | Lymphoma | PMID:150198 [Fam.AY:I.1(261)]; PMID:36105815 [Fam.I281M:I.1(father)] | |
106474 | M | 216027 | - | Egyptian | Hodgkin lymphoma | Immunodeficiency, common variable, 8 | PMID:32506362 [P9] |
106850 | M | 216169![]() |
8 | Caucasian | Hodgkin lymphoma | Adenosine deaminase 2 deficiency | PMID:29963054 [Fam.P1:II.2(P2)] |
*Age: age reported at the first known time of manifestation; PMID: PubMed ID; GRID: GenIA reference ID (ref. not in PubMed).